Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy

Aim: The study aims to evaluate protective effects of sophoricoside (Sop) on cardiac hypertrophy. Meanwhile, the potential and significance of Sop should be broadened and it should be considered as an attractive drug for the treatment of pathological cardiac hypertrophy and heart failure. Methods: U...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biosci Rep
Egile Nagusiak: Gao, Maomao, Hu, Fengjiao, Hu, Manli, Hu, Yufeng, Shi, Hongjie, Zhao, Guo-Jun, Jian, Chongshu, Ji, Yan-Xiao, Zhang, Xiao-Jing, She, Zhi-Gang, Li, Hongliang, Zhu, Lihua
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Portland Press Ltd. 2020
Gaiak:
Cardiovascular System & Vascular Biology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677750/
https://ncbi.nlm.nih.gov/pubmed/32964914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20200661
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak